Therefore, we believe that the use of D2R heterozygous (+/-) rather than null mice is a more appropriate choice to reflect the susceptibility of D2R deficiency to obesity in a clinical setting. This evidence concerns the gene DRD2 and obesity due to melanocortin 4 receptor deficiency.